Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results.

"Declarations Ethics approval and consent to participateAll procedures were performed in accordance with the tenets of the Declaration of Helsinki. The study was approved by Ethics Committee of the Hôpital Maisonneuve-Rosemont (Montreal, Canada) and was exempted from patient consent due to its retrospective nature. Consent for publicationAll named authors met the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work in its entirety, and have given their approval for this version to be published. Competing interestsPaul Harasymowycz is a consultant for Allergan, Alcon, Glaukos, Ivantis, J and J Vision, Santen, Novartis, and Bausch and Lomb. Ali Salimi and Harrison Watt have nothing to disclose. Competing interests Paul Harasymowycz is a consultant for Allergan, Alcon, Glaukos, Ivantis, J and J Vision, Santen, Novartis, and Bausch and Lomb. Ali Salimi and Harrison Watt have nothing to disclose."

"Funding No financial sponsorship was received for the work in this study."